Comparison of Point of Care to Lab INR in Dialysis Patients on Warfarin
NCT ID: NCT00660946
Last Updated: 2023-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
37 participants
OBSERVATIONAL
2005-06-30
2005-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fiix-prothrombin Time for Monitoring Warfarin
NCT01565239
Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies
NCT02610153
Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)
NCT03682419
Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A Multicenter, Non-concurrent Controlled Study
NCT06645275
Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability?
NCT00990158
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
37 dialysis patients
37 chronic hemodialysis patients on warfarin requiring Laboratory INR monitoring for anticoagulation management.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pharmacy Services Department, Mayo Clinic
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert W. Hoel, Pharm D
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic Rochester, Mn USA
References
Explore related publications, articles, or registry entries linked to this study.
Hoel RW, Albright RC, Beyer LK, Santrach PJ, Magtibay DL, Everson SL, McBane RD. Correlation of point-of-care International Normalized Ratio to laboratory International Normalized Ratio in hemodialysis patients taking warfarin. Clin J Am Soc Nephrol. 2009 Jan;4(1):99-104. doi: 10.2215/CJN.03360708. Epub 2008 Nov 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
618-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.